Organ-on-a-chip Market Analysis & Forecast, 2020 – 2025

The global organ-on-a-chip market generated revenue of US$ 23.3 million in 2020 and is expected to reach US$ 116.7 million by 2025 with a CAGR of 38.0% in the forecast period. The organ-on-a-chip market report offers a comprehensive market analysis of the different segments and regions that lets readers make crucial business-related decisions with a wealth of information enclosed in this report. The research report offers both qualitative and quantitative information on the global organ-on-a-chip market. In qualitative terms, the organ-on-a-chip market report provides insights into numerous factors, such as market determinants, value chain analysis, emerging trends, growth opportunity analysis, porters five-force model analysis and macro-economic factors, segment analysis, regional analysis at a granular level. Similarly, in quantitative terms, the report provides historical and forecast market numbers of organ-on-a-chip in various segments such as by Offerings, type, application & end-user at global, regional, and country-level. Also, the report provides a detailed analysis of the market vendors and their product offerings. The report also covers details of the competitive market environment and includes information on the capabilities and competencies of market vendors.

Segment Analysis

• The liver segment accounts for the dominating position in the market.  
  • Based on types, the organ-on-a-chip market is segmented into the liver, kidney, heart, lungs, and others. The liver segment holds the dominating position in the market in 2020 and is expected to retain its dominance throughout the forecast period. The concern with the changing lifestyle of peoples, all around the world has resulted in increasing liver failures and various diseases that have harmful effects on the functionality of the liver. Thus, with an increase in liver diseases, the demand for curing those diseases has also increased. This, in turn, is boosting usage of the liver-on-a-chip market.
• The toxicity testing application is expected to grow with the highest CAGR in the forecast period. 
  • Based on the application, the organ-on-a-chip market is segmented into drug discovery, physiological model, and toxicity testing. The toxicity testing application is expected to grow with the highest CAGR during the forecast period. Moreover, drug discovery holds a dominant market position in 2020 and is expected to remain dominant over the forecast period. Recently, organ-on-a-chip (OOC) technology has drawn attention to be used in drug development and drug testing model by reflecting the genetic characteristics of cells in each patient.
• The pharmaceuticals & biotechnology companies are expected to grow with the highest CAGR in the forecast period. 
  • Based on end-user, the organ-on-a-chip market is segmented into academics and research institutes, pharmaceuticals & biotechnology companies, the cosmetic industry, and others. The pharmaceuticals & biotechnology companies segment is expected to grow with the highest CAGR during the forecast period. Because OCC technological solutions are shifting from just academics to providing real-world solutions. Thus, more pharmaceutical and biotechnology companies are adopting this technology to perform research and produce better drugs, in turn providing a surge to the organ-on-a-chip market.
• North America accounts for the dominating position in the market. 
  • Based on the region, the organ-on-a-chip market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America is expected to contribute to the larger market share in 2020. The U.S. and Canada are the largest market-driven countries in this region owing to factors, such as the availability of a wide range of services offered by major players and an increase in toxicological testing of chemicals on the different types of organ cells. Moreover, Europe is projected to rise at the fastest CAGR in the forecast period. U.K., Germany, and France are some of the major market-driven countries in this region. The availability of advanced interventional products (including organ-on-a-chip), and increasing drug discovery to provide better treatments, are driving market growth in European countries.
• Organ-on-a-chip Market Players: 
  • Some of the major players in the organ-on-a-chip market are as follows:
    • Ascendance Biotechnology
    • AxoSim, Inc.
    • CN BIO Innovations Limited
    • Emulate, Inc.
    • Hµrel Corporation
    • InSphero AG
    • Kirkstall Ltd
    • Mimetas
    • SynVivo, Inc.
    • TissUse GmbH
  • The study also focuses on different business or inorganic market growth strategies through technology advancement, business expansion, alliances, and mergers and acquisitions to create disruptive technologies and consumer networks.